Insider Transactions in Q1 2024 at Spring Works Therapeutics, Inc. (SWTX)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 16
2024
|
Daniel Pichl Chief People Officer |
SELL
Open market or private sale
|
Direct |
15,000
-24.91%
|
$750,000
$50.1 P/Share
|
|
Feb 16
2024
|
Daniel Pichl Chief People Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+19.94%
|
$405,000
$27.64 P/Share
|
|
Feb 05
2024
|
Bhavesh Ashar Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
4,834
-7.67%
|
$236,866
$49.32 P/Share
|
|
Feb 02
2024
|
Bhavesh Ashar Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
3,222
-1.23%
|
$144,990
$45.11 P/Share
|
|
Feb 02
2024
|
Daniel Pichl Chief People Officer |
SELL
Open market or private sale
|
Direct |
26,181
-10.39%
|
$1,178,145
$45.13 P/Share
|
|
Feb 02
2024
|
Daniel Pichl Chief People Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,250
+18.54%
|
$438,750
$27.64 P/Share
|
|
Jan 08
2024
|
Michael Nofi Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,063
-3.57%
|
$43,583
$41.53 P/Share
|
|
Jan 08
2024
|
Perier I Francis Jr Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,215
-5.15%
|
$131,815
$41.53 P/Share
|
|
Jan 08
2024
|
Daniel Pichl Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,405
-2.48%
|
$57,605
$41.53 P/Share
|
|
Jan 08
2024
|
Saqib Islam Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
17,904
-6.53%
|
$734,064
$41.53 P/Share
|
|
Jan 08
2024
|
L. Mary Smith Chief Development Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,535
-1.49%
|
$144,935
$41.53 P/Share
|
|
Jan 08
2024
|
Herschel S Weinstein General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
2,423
-4.43%
|
$99,343
$41.53 P/Share
|
|
Jan 08
2024
|
Bhavesh Ashar Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,449
-2.14%
|
$59,409
$41.53 P/Share
|
|
Jan 08
2024
|
James Cassidy Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,093
-1.41%
|
$44,813
$41.53 P/Share
|
|
Jan 08
2024
|
Badreddin Edris Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,466
-1.99%
|
$224,106
$41.53 P/Share
|
|
Jan 05
2024
|
Michael Nofi Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,169
-3.78%
|
$43,253
$37.96 P/Share
|
|
Jan 05
2024
|
Perier I Francis Jr Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,151
-3.33%
|
$79,587
$37.96 P/Share
|
|
Jan 05
2024
|
Daniel Pichl Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,574
-2.71%
|
$58,238
$37.96 P/Share
|
|
Jan 05
2024
|
Saqib Islam Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,885
-4.49%
|
$476,745
$37.96 P/Share
|
|
Jan 05
2024
|
L. Mary Smith Chief Development Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,197
-0.92%
|
$81,289
$37.96 P/Share
|
|
Jan 05
2024
|
Herschel S Weinstein General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
2,324
-4.08%
|
$85,988
$37.96 P/Share
|
|
Jan 05
2024
|
Bhavesh Ashar Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,507
-3.57%
|
$92,759
$37.96 P/Share
|
|
Jan 05
2024
|
James Cassidy Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,357
-2.95%
|
$87,209
$37.96 P/Share
|
|
Jan 05
2024
|
Badreddin Edris Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,469
-1.6%
|
$165,353
$37.96 P/Share
|
|
Jan 04
2024
|
Tai An Lin Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,289
+15.3%
|
-
|
|
Jan 04
2024
|
Michael Nofi Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,104
+31.3%
|
-
|
|
Jan 04
2024
|
Perier I Francis Jr Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,156
+24.66%
|
-
|
|
Jan 04
2024
|
Daniel Pichl Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,919
+28.28%
|
-
|
|
Jan 04
2024
|
Saqib Islam Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
88,000
+23.46%
|
-
|
|
Jan 04
2024
|
L. Mary Smith Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,156
+8.13%
|
-
|
|
Jan 04
2024
|
Herschel S Weinstein General Counsel & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
21,156
+27.07%
|
-
|
|
Jan 04
2024
|
Bhavesh Ashar Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
26,445
+27.37%
|
-
|
|
Jan 04
2024
|
James Cassidy Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,208
+26.1%
|
-
|
|
Jan 04
2024
|
Badreddin Edris Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
42,312
+13.15%
|
-
|